Using a sequencing approach called PANDORA-seq, researchers searched for previously hidden small RNAs in the liver, the organ that controls cholesterol metabolism. They identified a single molecule, tsRNA-Glu-CTC, that was highly abundant in the liver and whose levels changed with cholesterol; the team reported that it made up more than 65% of the detectable tRNA-derived small RNAs in their samples.
The study linked tsRNA-Glu-CTC to SREBP2 (Sterol Regulatory Element-Binding Protein 2), a key protein that acts as a master regulator of cholesterol production. Higher tsRNA-Glu-CTC boosted SREBP2 activity and turned on genes that synthesize cholesterol.
In mice, researchers used an antisense oligonucleotide (ASO) to lower tsRNA-Glu-CTC. Lowering the molecule reduced cholesterol and led to less severe atherosclerosis. A naturally chemically modified form of the RNA was more effective than synthetic versions, and human blood samples showed a similar association between elevated tsRNA-Glu-CTC and higher circulating cholesterol.
Difficult words
- sequence — to identify the order of genetic materialsequencing
- metabolism — chemical processes in the body that use energy
- regulator — a molecule or protein that controls activity
- synthesize — to make a chemical substance inside cells
- antisense oligonucleotide — a short strand made in a lab that blocks RNA
- modified — chemically changed to have a different form
- abundant — present in large amounts or numbers
- atherosclerosis — a disease where arteries become narrow with fat
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- How could lowering a molecule like tsRNA-Glu-CTC help people with high cholesterol? Explain briefly.
- What might be advantages or concerns of using a naturally chemically modified RNA instead of a fully synthetic drug?
- What further tests or information would you want before a treatment like this is offered to people?
Related articles
Study: Year‑round RSV Immunization Could Reduce Big Outbreaks
A study in Science Advances finds that offering RSV immunizations year‑round would lower the chance of large seasonal outbreaks in the United States. Researchers compared spread in cities and rural areas and tested seasonal versus year‑round schedules.
AI to stop tobacco targeting young people
At a World Conference in Dublin (23–25 June), experts said artificial intelligence can help stop tobacco companies targeting young people online. They warned social media and new nicotine products draw youth into addiction, and poorer countries carry the heaviest burden.
Human heart organoids model atrial fibrillation
Scientists made small, beating human heart‑like organoids from donated stem cells and added immune cells. When they caused inflammation the organoids showed irregular heartbeats like atrial fibrillation; an anti‑inflammatory drug partly restored rhythm.
